Mon panier

Cadherin-17

Cadherin-17 Informations sur la molécule

Nom anglaisCadherin-17Nombre de médicaments commercialisés0
Nombre de médicaments cliniques17Alias de la cibleLiver-intestine cadherin,HPT-1,Intestinal peptide-associated transporter HPT-1,LI-cadherin,HPT-1 Cadherin,Cadherin 17, LI Cadherin (Liver-Intestine),HPT1,Human Intestinal Peptide-Associated Transporter HPT-1,LI Cadherin,Cadherin,Cadherin 17,Human Peptide Transporter 1
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisCadherin-17
Alias de la cibleLiver-intestine cadherin,HPT-1,Intestinal peptide-associated transporter HPT-1,LI-cadherin,HPT-1 Cadherin,Cadherin 17, LI Cadherin (Liver-Intestine),HPT1,Human Intestinal Peptide-Associated Transporter HPT-1,LI Cadherin,Cadherin,Cadherin 17,Human Peptide Transporter 1
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques17
Phase de R&D la plus avancéePhase 2 Clinical

Cadherin-17 Liste de produits

  • Attribut

    Protein (30)Cell (1)

  • Bibliothèque de produits

    En ligne (31)

  • Espèces

    Mouse (4)Human (22)Rat (1)Cynomolgus (3)Rhesus macaque (1)

  • Étiquette

    His Tag (11)His Tag & Avi Tag (4)Mouse IgG Fc Tag (1)Fc Tag (12)Fc Tag & Avi Tag (2)- (1)

  • Marqueur

    Unconjugated (23)Biotin-labeled (6)- (1)FITC Labeled (1)

Cadherin-17Contexte de la molécule

Cadherin-17, also known as liver-intestine (LI) Cadherin, belongs to the cadherin family of calcium-dependent cell adhesion molecules. In vivo studies showed CDH17 knockout resulted in apoptotic PC tumor death through activating caspase-3 activity. Taken together, CDH17 functions as an oncogenic molecule critical to PC growth by regulating tumor apoptosis signaling pathways and CDH17 could be targeted to develop an anti-PC therapeutic approach.

Cadherin-17Alias de la molécule

Cadherin-17,CDH17,HPT-1,LI-cadherin

Plateforme de commerce de projets d'anticorps

Nom du projetPhase du projetType de moléculeSource de moléculeDomain thérapeutiqueIndication
CDH17 mAb - 01PCCMonoclonalHumanized MouseSolid TumorColorectal cancer,Gastric Cancer

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
LM-350LM-350Phase 2 ClinicalLaNova Medicines LtdGastrointestinal Neoplasms; Neoplasms; Solid tumours
Details
7MW-49117MW-4911Phase 2 ClinicalMabwell (Shanghai) Bioscience Co LtdColorectal Neoplasms; Gastrointestinal Neoplasms; Solid tumours
Details
CM518D1CM518D1; CM-518-D-1Phase 2 ClinicalKeymed Biosciences Co LtdSolid tumours
Details
HS-20110HS20110; HS-20110Phase 2 ClinicalChangzhou Hengbang Pharmaceutical Co Ltd, Shanghai Hansoh Biomedical Co LtdCarcinoma, Renal Cell; Colorectal Neoplasms; Solid tumours
Details
AMT-676AMT-676Phase 2 ClinicalMultitude Therapeutics IncColorectal Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
CHM-2101CDH17-CAR T; CHM-2101; CHM2101; CHM-2101 CAR-T cellsPhase 2 ClinicalUniversity Of PennsylvaniaColorectal Neoplasms; Gastrointestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Stomach Neoplasms
Details
MRG-007MRG-007; ARR-217Phase 2 ClinicalLepu Biopharma Co LtdColorectal Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
BI-905711BI-905711Phase 1 ClinicalBoehringer Ingelheim International GmbhCholangiocarcinoma; Gastrointestinal Neoplasms; Pancreatic Neoplasms
Details
CabotamigARB-202Phase 1 ClinicalArbele CorpBiliary Tract Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal adenocarcinoma; Gastrointestinal Neoplasms; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Stomach Neoplasms
Details
HDM-2017HDM-2017; HDM2017Phase 1 ClinicalHangzhou Zhongmei Huadong Pharmaceutical Co LtdColorectal Neoplasms; Solid tumours
Details
SIM-0609SIM-0609; SIM0609Phase 1 ClinicalShanghai Xianwei Pharmaceutical Technology Co LtdGastrointestinal Neoplasms; Neoplasm Metastasis; Solid tumours
Details
UCLH-801UCLH-801Phase 1 ClinicalUTC Therapeutics IncBiliary Tract Neoplasms; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Neoplasms; Stomach Neoplasms
Details
Anti-CDH17 CAR-T cells Therapy (Guangzhou Bio-Gene Technology)Phase 1 ClinicalGuangzhou Bio-Gene Technology Co LtdSolid tumours
Details
Anti-CDH17 CAR-T Cell therapy (UTC Therapeutics)Phase 1 ClinicalUTC Therapeutics IncSolid tumours
Details
YL-217YL217; YL-217Phase 1 ClinicalMediLink Therapeutics Co LtdSolid tumours
Details
TORL-3-600TORL-3-600Phase 1 ClinicalTorl Biotherapeutics LLCColorectal Neoplasms; Solid tumours
Details
CDH17 - IHC Test(Arbele)ClinicalArbele CorpGastrointestinal Neoplasms
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques